Evidence-based guidelines for the pharmacological treatment of anxiety 
disorders: recommendations from the British Association for Psychopharmacology

Baldwin, D. S.; Anderson, I. M.; Nutt, D. J.; Bandelow, B.; Bond, A.; Davidson, J. R. T.; den Boer, J. A.; Fineberg, N. A.; Knapp, M.; Scott, J.; Wittchen, H. U.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

MPS-Authors

/persons/resource/persons80592

Wittchen, H. U.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., et al. (2005). Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 19(6), 567-596.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-99F4-6

Abstract

There is no abstract available